Medical News: CHF Registry Shows Survival Difference With ARBs - in Cardiovascular, CHF from MedPage Today
Links shared publicly online about this topic.
- 587total visits
Medical News: CHF Registry Shows Survival Difference With ARBs - in Cardiovascular, CHF from MedPage Today
Heart failure patients lived significantly longer when treated with candesartan (Atacand) than with losartan, data from a patient registry showed.
View full resource at medpagetoday.com
Tags: Heart, Heart Disease, Heart Failure, High Blood Pressure Medication, Healthy Living, News
Most Recently Shared on January 12, 2011 at 3:45 pm By:
Research: CHF registry shows survival difference with ARBs (JAMA) http://bit.ly/eq2jGT - #health
Also Shared By:
Advertisement
Yvo Sijpkens MD
@ysijp
Heart failure patients live significantly longer when treated with candesartan than with losartan: http://bit.ly/hsW0rc
1 year ago...